öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£º¼ÎºìÔÆ
ÐÔ±ð£ºÅ®
ÈËÆøÖ¸Êý£º51

ËùÊôԺУ£º¹ãÖÝÒ½¿Æ´óѧ
ËùÊôԺϵ£º
Ö°³Æ£º½ÌÊÚ
µ¼Ê¦ÀàÐÍ£ºË¶µ¼
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÁÙ´²¼ìÑéÕï¶Ïѧ
Ñо¿ÁìÓò£º Ö×Áö·¢ÉúºÍÄÍÒ©»úÖÆ
Ñо¿ÁìÓò£º Ö×Áö·¢ÉúºÍÄÍÒ©»úÖÆ [ÊÕÆð]




¸öÈ˼òÊö :
¼ÎºìÔÆ£¬Å®£¬ 1976Äê6Ô³öÉú£¬¼®¹áɽÎ÷£¬Öй²²úµ³Ô±£¬Ñ§ÀúÑо¿Éú£¬Ò½Ñ§²©Ê¿Ñ§Î»£¬¹ãÖÝÒ½¿Æ´óѧ¸½ÊôµÚ¶þÒ½Ôº¼ìÑé¿Æ£¬Ë¶Ê¿Ñо¿Éúµ¼Ê¦¡£

¿ÆÑй¤×÷ :
¹¤×÷Òµ¼¨
Ö÷Òª´ÓÊÂÖ×Áö·¢ÉúºÍÄÍÒ©»úÖƵÄÑо¿£¬ÊìϤÄÍҩϸ°ûÖêµÄÓÕµ¼ÅàÑø£¬ÄÍÒ©»úÖƵÄÑо¿£¬²¢ÔÚ·Ö×ÓÉúÎïѧºÍ·Ö×Ó²¡¶¾Ñ§Ñо¿·½Ãæ»ýÀÛÁ˷ḻ¾­Ñé¡£Ö÷³Ö¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÒ»Ï£¨**£©ÏîÄ¿Ãû³Æ: miR-541ͨ¹ýSrc¼¤Ã¸ÔÚÂýÐÔÁ£Ï¸°û°×Ѫ²¡ÄÍÒ©¼à²âÖеĻúÖÆÑо¿£»2011Äê¹ãÖÝÊÐÒ½Ò©ÎÀÉú¿Æ¼¼ÏîÄ¿£¨201102A213018£©£¬ÏîÄ¿Ãû³Æ£ºSrc¼¤Ã¸ÔÚÂýÐÔËèϸ°û°×Ѫ²¡ÄÍÒ©ÖÐ×÷ÓûúÖÆÑо¿¡£Ö÷³Ö¹ãÖÝÊпƼ¼ºÍÐÅÏ¢»¯¾ÖÏîÄ¿£ºmiR-26b°ÐÏòUSP9XÔڸΰ©Ï¸°ûEMT×÷ÓûúÖÆÑо¿£¨2014J**£©¡£
½üÆÚÂÛÎÄ
Ö÷Òª¿ÆÑÐÂÛÎÄ£º1. Shen G, Jia H, Tai Q, Li Y, Chen D. miR-106b downregulates adenomatous polyposis coli and promotes cell proliferation in human hepatocellular carcinoma. Carcinogenesis. 2013 Jan34(1):211-9.2. Jia HY, Wu JX, Zhu XF, Chen JM, Yang SP, Yan HJ, Tan L, Zeng YX, Huang W. ZD6474 inhibits Src kinase leading to apoptosis of imatinib-resistant K562 cells. Leuk Res. 2009 33:1512-9. 3. Tan L, Jia H, Liu R, Wu J, Han H, Zuo Y, Yang S, Huang W. Inhibition of NF-kappaB in fusogenic membrane glycoprotein causing HL-60 cell death: implications for acute myeloid leukemia. Cancer Lett **:114-21. 4. Wu J, Xiao X, Jia H, Chen J, Zhu Y, Zhao P, Lin H, Huang W. Dynamic distribution and expression in vivo of human interferon gamma gene delivered by adenoviral vector. BMC Cancer 200916:55.5. Yang S, Wu J, Zuo Y, Tan L, Jia H, Yan H, Zhu X, Zeng M, Ma J, Huang W. ZD6474, a Small Molecule Tyrosine Kinase Inhibitor, Potentiates the Anti-Tumor and Anti-Metastasis Effects of Radiation for Human Nasopharyngeal Carcinoma. Curr Cancer Drug Targets 2010 Sep10(6):611-22.6. Gang Shen, Ye Lin£¬Xuewei Yang, Jing Zhang, Zhe Xu, Hongyun Jia*£¨Í¨Ñ¶×÷Õߣ©MicroRNA-26b inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting USP9X£¬submitted£¬BMC Cancer.7. ¼ÎºìÔÆ£¬ÎâÏþÂû£¬ÍõÖÒÓ¢£¬µÈ. ZD6474¶ÔÒÁÂíÌæÄáÄÍÒ©µÄK562ϸ°ûÔöÖ³µÄÓ°Ï죬ÖлªÑªÒºÑ§ÔÓÖ¾£¬2010,31(6): 371-375.8. ¼ÎºìÔÆ£¬Àî¾ê£¬µËСÑ࣬µÈ. ÒÖÖÆSrc¼¤Ã¸¶ÔÂýÐÔÁ£Ï¸°û°×Ѫ²¡Ï¸°ûÒÖÖÆ×÷Ó㬹㶫ҽѧ£¬2011,32(20):2625-2628.9. ¼ÎºìÔÆ£¬Àî¾ê£¬ÍõÖÒÓ¢£¬µÈ. Src¼¤Ã¸ÒÖÖƼÁZD6474¶Ô°×Ѫ²¡ÄÍҩϸ°ûϵK562/A02ÔöÖ³µÄÓ°Ï켫Æä×÷ÓûúÖÆ̽ÌÖ, ÖлªÑªÒºÑ§ÔÓÖ¾£¬2012£¬33(3)220-224.10. ¼ÎºìÔÆ£¬ÖÜÇ¿£¬Àî¾ê£¬µÈ. ¹ý±í´ïSrcÓÕµ¼K562ϸ°û²úÉúImatinibÄÍÒ©£¬ÊµÓÃҽѧÔÓÖ¾£¬2012,28(12):18-20.11. Ô­·¢ÐÔѪС°å¼õÉÙÐÔ×Ïñ°Æ¢¹¦ÄÜ¿º½ø¼°¾ÞºËϸ°ûÐÎ̬ѧ¹Û²ì,º£ÄÏҽѧԺѧ±¨,2012.18(5):592-593. 12. 2ÏîÁªºÏ¼ì²â×÷ΪѪС°å»î»¯ÌØÒìÐÔ±êÖ¾ÎïµÄÆÀ¼Û,¼ìÑéҽѧÓëÁÙ´².2012,9(9):1034-1035. 13. ³ÂºÆÓÖÓÔ¶ºì£¬ÎâÏþÂû£¬¼ÎºìÔÆ(ͨѶ×÷Õß)£¬Í¬ÐÍ°ëë×°±ËáÁªºÏD-¶þ¾ÛÌå¶Ô¸Î°©ÑªË¨Ç°×´Ì¬¼à²âµÄÑо¿£¬¼ìÑéҽѧÓëÁÙ´²£¬2013£¬10£¨22£©:2952-2955.


½ÌÓý±³¾° :
ѧϰ¾­Àú£º£±£¹£¹£¸Äê±ÏÒµÓÚɽÎ÷Ò½¿Æ´óѧ£¬»ñѧʿѧλ£»199£¹Äê±ÏÒµÓÚɽÎ÷Ò½¿Æ´óѧ£¬»ñ˶ʿѧλ£»£²£°£°£µÄê¹¥¶ÁÖÐɽҽ¿Æ´óѧ²©Ê¿Ñ§Î»£¨ÏÖÖÐɽ´óѧ£©£¬´ÓʦÓÚÖÐɽ´óѧ»ÆÎÄÁÖ½ÌÊÚ¡£